• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-300M-K
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Unspecified Infection (1930)
Event Date 01/26/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).(b)(6) 2016 - initial implant procedure lasted 3 hours, patient did not have vns and did not undergo invasive monitoring.This is the centers 12th implant.Vancomycin powder was used and the sutures were used at close.The system included the rns neurostimulator and two depth leads.Port 1 , sn (b)(4) left mesial temporal.Port 2 sn (b)(4) right mesial temporal - previous resection.Burr hole cover was used.Device not returned to manufacturer.
 
Event Description
(b)(6) 2017 the patient reported having 'headaches.' (b)(6) 2017- the patient had a ct scan.Seen at center where csf results and ct scan were abnormal.(b)(6) 2017 the patient was admitted and started on iv antibiotics.(b)(6) 2017 patient presented: to er reporting that 1 week prior to er visit, he had an increase in falls, headaches, chills, personality change, lethargy, decreased appetite, word confusion for five days.Fever observed in ed.Ct brain indicated bifrontal hypodensities.(b)(6) 2017-center notified fce that patient had undergone a complete explant of the rns system secondary to probable bacterial infection.Treatment details : (b)(6) 2017 - started broad spectrum abx: ceftriaxone, vancomycin, metronidazole, ampicillin and acyclovir then rns system was explanted.Placement of a picc for long term antibiotics.(b)(6) 2017 continuation of vancomycin, acyclovir, discontinue metronidazole, ampicillin, cefepime, start meropenem, (b)(6) 2017 discontinue acyclovir, (b)(6) 2017 discontinue meropenem, vancomycin, continue ceftriaxone (end of treatment (b)(6) 2017).(b)(6) 2017 the patient was discharged with iv antibiotics for 10 days.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key6346450
MDR Text Key67870955
Report Number3004426659-2017-00008
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005120
UDI-Public010085554700512017170330
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 02/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberRNS-300M-K
Device Catalogue Number1007603
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/24/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age56 YR
-
-